T1	Participants 188 196	Japanese
T2	Participants 79 139	after autologous blood stem cell transplantation in children
T3	Participants 270 408	74 children who were scheduled to undergo high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT)
T4	Participants 1853 1858	PBSCT
T5	Participants 1008 1125	11 patients were excluded due to disease progression before PBSCT (n = 6) or a low number of harvested cells (n = 5),
T6	Participants 3372 3414	G-CSF therapy in children undergoing PBSCT
